M. (2012). Characterization of Genes Encoding for Acquired Bacitracin Resistance in Clostridium perfringens. PLoS ONE, 7(9), e44449. https://doi.org/10.1371/journal.pone.0044449 Draper, L. A., Cotter, P. D., Hill, C., & Ross, R. P. (2015). Lantibiotic Resistance. Microbiology and Molecular Biology Reviews, 79(2), 171–191. https://doi.org/10.1128/MMBR.00051-14 Hakulinen, J. K., Hering, J., Brändén, G., Chen, H., Snijder, A., Ek, M., & Johansson, P. (2017). MraY- antibiotic complex reveals details of tunicamycin mode of action. Nature Chemical Biology, 13(3), 265–267. https://doi.org/10.1038/nchembio.2270 Han, X., Du, X.-D., Southey, L., Bulach, D. M., Seemann, T., Yan, X.-X., … Rood, J. I. (2015). Functional Analysis of a Bacitracin Resistance Determinant Located on ICE Cp1 , a Novel Tn 916 - Like Element from a Conjugative Plasmid in Clostridium perfringens. Antimicrobial Agents and Chemotherapy, 59(11), 6855–6865. https://doi.org/10.1128/AAC.01643-15 Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010). Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications. Clinical Microbiology Reviews, 23(1), 99–139. https://doi.org/10.1128/CMR.00042-09